DRAK2 anticorps (Center)
Aperçu rapide pour DRAK2 anticorps (Center) (ABIN7297570)
Antigène
Voir toutes DRAK2 (STK17B) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Center
-
Fonction
- Rabbit polyclonal antibody to STK17B
-
Specificité
- Recognizes endogenous levels of STK17B protein.
-
Attributs du produit
- Rabbit polyclonal antibody to STK17B
-
Purification
- The antibody was purified by immunogen affinity chromatography.
-
Immunogène
- KLH-conjugated synthetic peptide encompassing a sequence within the center region of human STK17B. The exact sequence is proprietary.
-
-
-
-
Indications d'application
- WB (1/500 - 1/1000), IH (1/100 - 1/200)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
-
Autre désignation
- STK17B
-
Sujet
- DRAK2, Serine/threonine-protein kinase 17B, DAP kinase-related apoptosis-inducing protein kinase 2
-
ID gène
- 9262, 98267, 170904
-
UniProt
- O94768
Antigène
-